Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
05/2007
05/29/2007US7223780 Triazole-derivatives as blood clotting enzyme factor Xa inhibitors
05/29/2007US7223778 5-substituted-2-arylpyridines
05/29/2007US7223777 Such as 1-(2-thien-2'-yl- 2-oxoethyl)-3-((3-phenylmethyl) pyrazol-5-yl)pyridinium bromide for treating diseases caused by the accumulation of AGE (Advanced Glycation Endproducts); antidiabetic/ antiaging agents
05/29/2007US7223776 Compounds with anti-bacterial activity
05/29/2007US7223768 Fused ring heterocycles as potassium channel modulators
05/29/2007US7223758 Such as (3S)-2-[3-[(phenylacetyl)amino]-1-oxopropyl]-N-[cyano(3-phenoxyphenyl)methyl]hexahydro-3-pyridazinecarboxamide; for treatment of osteoporosis, hypercalcaemia, osteoporosis, gingival disease, arthritis, Paget's disease, and bone cancer
05/29/2007US7223757 Such as (S)-4-[2-(3-Chloro-phenyl)-2-hydroxy-ethylamino]-3-{6-[4-(2-methoxy-ethyl)-piperazin-1-yl]-4-methyl-1H-benzimidazol-2-yl}-1H-pyridin-2-one bis hydrochloride; anticancer agents; antiproliferative agents
05/29/2007US7223756 Treatment of autoimmune diseases, transplant rejection and rheumatoid arthritis with a quinazoline 4-substituted by a methylenedioxyphenyl group linked to the ring by an ether, methyl, sulfide, sulfoxide or sulfone, e.g., 6-methoxy-4-(2,3-methylenedioxyphenoxy)-7-(3-pyrrolidin-1-ylpropoxy)quinazoline,
05/29/2007US7223749 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
05/29/2007CA2214565C New cryptophycins from synthesis
05/24/2007WO2007058602A2 Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer’s disease, neurodegeneration and dementia.
05/24/2007WO2007058601A1 Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer’s disease, neurodegeneration and dementia
05/24/2007WO2007058392A1 Heterocyclic compound and medicinal application thereof
05/24/2007WO2007058338A2 Oxazole compound and pharmaceutical composition
05/24/2007WO2007057775A1 Spiropiperidine derivatives
05/24/2007WO2007057229A1 4-oxadiazolyl-piperidine compounds and use thereof
05/24/2007WO2007027527A3 Isoindole-imide compounds and compositions comprising and methods of using the same
05/24/2007WO2006138304A3 Pyrimidine compounds
05/24/2007WO2006133397A3 Process for the synthesis of triazoles
05/24/2007WO2006021654A8 4-arylmorpholin-3-one derivatives, preparation and therapeutic use thereof
05/24/2007US20070117977 Process for the production of DTPA-BIS anhydride
05/24/2007US20070117850 substituted or unsubstituted 2-pyridyl moiety and a pyrozole ring substituted at 4 position with pyridine ring; inhibits the TGF-beta signaling pathway; anticancer, antifibrotic, antitumor, and antiproliferative agents
05/24/2007US20070117817 Pyrimidine derivatives for treatment of hyperproliferative disorders
05/24/2007US20070117798 Morpholine type cinnamide compound
05/24/2007US20070117795 Methods and compositions of novel triazine compounds
05/24/2007US20070117787 N-[(3R,5S)-1-(3-Acetoxy-2,2-dimethylpropyl)-7-chloro-5-(2,3-dimethoxyphenyl)-2-oxo-1,2,3,5-tetrahydro-4,1-benzoxazepine-3-acetyl]piperidine-4-acetic acid; in combination with a statin, lowering cholesterol-level and lowering triglyceride-level
05/24/2007CA2630680A1 Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer~s disease, neurodegeneration and dementia.
05/24/2007CA2628750A1 4-oxadiazolyl-piperidine compounds and use thereof
05/24/2007CA2627541A1 Oxazole compound and pharmaceutical composition
05/23/2007EP1786807A1 Heterocyclic antiviral compounds
05/23/2007EP1786806A1 Dpp-iv inhibitors
05/23/2007EP1786805A1 Oxazolidinone compounds and compositions and methods related thereto
05/23/2007EP1786801A1 Cytokine inhibitors
05/23/2007EP1786800A2 Substituted biaryl piperazinyl-pyridine analogues
05/23/2007EP1786777A1 Aminoheteroaryl compounds as protein tyrosine kinase inhibitors
05/23/2007EP1786775A1 Dimeric piperidine derivates
05/23/2007EP1786762A2 Amidine substituted aryl aniline compounds
05/23/2007EP1651641B1 Nicotinamide derivatives useful as pde4 inhibitors
05/23/2007EP1423384B1 Pyridine derivatives as raf kinase inhibitors
05/23/2007EP1369419B1 N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same
05/23/2007EP1254895B1 Nitrogenous cyclic compounds and pharmaceutical compositions containing the same
05/23/2007EP1238974B1 Heterocycle derivatives and drugs
05/23/2007EP1181014B1 HETEROCYCLIC CONTAINING BIPHENYL aP2 INHIBITORS AND METHOD
05/23/2007CN1968950A Pyridinylisoxazoles and their use as herbicides
05/23/2007CN1968949A Proline derivatives and their use as dipeptidyl peptidase IV inhibitors
05/23/2007CN1968947A Heterocyclic condensed compounds useful as antidiuretic agents
05/23/2007CN1968929A Substituted tetrahydro-2h-isoquinolin-1-one derivatives, method for the production thereof, and use of the same as medicaments
05/23/2007CN1966503A 2,6-dimethyl-3,5-bi-(2-methyl-3-N-acetyl-5-phenyl-[1,3,4] oxadiazoles) pyridine and its synthesis method
05/23/2007CN1966502A Functionalized picolinic acid double dentate anion ligand and its annular metal iridium complex and uses
05/23/2007CN1317279C 3(2H)-pyridazinone derivative and its preparing process and application
05/23/2007CN1317278C Heterocyclic compounds and their use as medicines
05/23/2007CN1317274C 1-phenyl-2-heteroaryl-substituted benzimdazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives
05/22/2007US7220871 taxane is prepared by esterifying an appropriate baccatin carrying a C-13 hydroxyl functional group with an acid derivative and is obtained by controlled saponification
05/22/2007US7220865 For therapy of neurodegenerative and/or neurological disorders, e.g., Alzheimer's disease, in a mammal
05/22/2007US7220864 Peroxisome proliferator activator controller; dietetics; antidiabetic agents; cardiovascular disorders; antidiabetic agents; hypoglycemic agents; antilipemic agenst
05/22/2007US7220781 Meta-benzamidine derivatives as serine protease inhibitors
05/22/2007US7220771 Jun n-terminal kinase inhibitors
05/22/2007US7220770 preferably selectively inhibit cyclooxygenase-2 over cyclooxygenase-1; arthritis treament
05/22/2007US7220768 Prevention reproduction of herpes virus
05/22/2007US7220767 Pharmaceutical formulations containing zolmitriptan
05/22/2007US7220760 1-carbonyl-4-carbonylaminotetrahydroquinoline derivatives; especially treating asthma and allergic rhinitis
05/22/2007US7220751 E.g., Cis-4-amino-cis-2-methyl-N-(6-methyl-2-(2-(2-pyridyl) ethenyl) quinazolin-4-yl)cyclohexylamine trihydrochloride; a nociceptin opiod-receptor agonist or antagonist effecting chronic pain and allodynia accompanied with herpes zoster
05/22/2007US7220750 Quinoline or quinazoline derivatives; antitumor agent, treating respiratory tract and gastrointestinal disorders
05/22/2007US7220746 For therapy of bronchitis, allergic bronchitis, bronchial asthma, emphysema, COPD and allergic rhinitis
05/22/2007US7220745 Viricides; therapy for hepatitis virus infections
05/22/2007US7220743 Heterocyclic CB1 receptor antagonists
05/22/2007US7220742 For therapy of respiratory complaints
05/22/2007US7220739 Therapeutic application of pro-apoptotic benzodiazepines
05/22/2007US7220736 Pyrimidine compounds
05/22/2007US7220735 And aza- and diaza-derivatives thereof; especially treating allergy or nasal congestion
05/22/2007US7220734 1-(amino)indanes and (1,2-dihydro-3-amino)-benzofurans, benzothiophenes and indoles as Edg receptor agonists
05/22/2007CA2286870C Indazole amide compounds as serotoninergic agents
05/22/2007CA2241466C Pharmaceutical composition containing angiotensin ii antagonist
05/22/2007CA2241263C N-arylsulfilimine compounds and their use as catalysts in the preparation of n-arylarylsulfonamide compounds
05/18/2007WO2007056497A1 Compounds and compositions as ppar modulators
05/18/2007WO2007055183A1 Benzene derivative or salt thereof
05/18/2007WO2007054480A1 2-(benzimidazol-1-yl)-acetamide biaryl derivatives and their use as inhibitors of the trpv1 receptor
05/18/2007WO2007054470A1 Use of rylene derivatives as photosensitizers in solar cells
05/18/2007WO2007054453A2 Carbocyclic fused cyclic amines as inhibitors of the coagulation factor xa
05/18/2007WO2007054444A2 3-aryl-isoxazole-4-carbonyl-benzofuran derivatives
05/18/2007WO2007035841A9 Analogs of dehydrophenylahistins and their therapeutic use
05/18/2007WO2007029037A3 Class iia histone deacetylase (hdac) substrate
05/18/2007WO2007029036A3 Amino acid derivatives as histone deacetylase (hdac) inhibitors
05/18/2007WO2007029035A3 Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors
05/18/2007WO2007028083A3 6-arylalkylamino- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
05/18/2007WO2007014934A8 Quinoline derivatives as antibacterial agents
05/18/2007WO2007002254A3 Benzocycloheptapyridines as inhibitors of the receptor tyrosine kinase met
05/18/2007WO2006138259A3 Chemokine receptor binding compounds
05/18/2007WO2006041635A8 Arylthiobenzylpiperidine derivatives
05/18/2007CA2628667A1 3-aryl-isoxazole-4-carbonyl-benzofuran derivatives
05/18/2007CA2627426A1 Carbocyclic fused cyclic amines as inhibitors of the coagulation factor xa
05/18/2007CA2627263A1 2-(benzimidazol-1-yl)-acetamide biaryl derivatives and their use as inhibitors of the trpv1 receptor
05/18/2007CA2626446A1 Compounds and compositions as ppar modulators
05/17/2007US20070112201 Intermediates to a copper bisoxazoline catalyst for asymmetric synthesis of agrochemical or pharmaceutical intermediates such as insecticides; reacting a cycloalkylidenemalonic diester with an aminoalcohol to form amide intermediate; cyclization to ligand e.g. 1,1-bis[2-[tert-butyloxazoline]]cyclopropane
05/17/2007US20070112192 3-(2-Hydroxy-phenyl)-1h-pyrazole-4-carboxylic acid amide derivatives as hsp90 inhibitors for the treatment of cancer
05/17/2007US20070112047 e.g. 2-[4-(1-cyclobutylaminoethyl)phenyl]-1H-benzimidazole-4-carboxamide; poly-ADP-ribose polymerase inhibitor; antiinflammatory, anticarcinogenic, antidiabetic, antiischemic agent; neurodegenerative diseases
05/17/2007US20070112040 Amino nicotinate derivatives as glucokinase (GLK) modulators
05/17/2007US20070112037 Pyrazole Derivatives
05/17/2007US20070112036 Opioid receptor antagonists
05/17/2007US20070112035 Substituted oxyarenes